ClinicalTrials.gg
CompletedNCT03272139STBUpdated May 11, 2022Results posted

Interscalene Block Versus Superior Trunk Block

A Phase 4 interventional study of Bupivacaine and Ultrasound in Joint Disease, Pain and Pain, Acute, sponsored by Hospital for Special Surgery, New York. Completed at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2022-05-11.

Sponsored by Hospital for Special Surgery, New York · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
126
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Sparing the phrenic nerve by administering ultrasound-guided low volume superior trunk block (STB) and interscalene block (ISB) for arthroscopic shoulder surgery (labral repair, stabilization, rotator cuff repair).

02

Conditions studied

  • Joint Disease
  • Pain
  • Pain, Acute
  • Pain, Chronic
03

In context

Joint Diseases

386 studies on the registry are indexed under Joint Diseases; 64 are open to participants now.

This study's enrollment of 126 is above the median of 102 across 251 interventional studies indexed under Joint Diseases.

Browse Joint Diseases studies →

Lead sponsor

Hospital for Special Surgery, New York is the lead sponsor of 226 studies on the registry; 40 are open to participants now.

Of its 30 completed or terminated interventional studies of FDA-regulated products, 22 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients who will be undergoing primary unilateral labral repair/stabilization of the shoulder
  • Age 18 to 80 years
  • Planned use of general anesthesia with LMA and interscalene or superior trunk block
  • Ability to follow study protocol
  • English speaking

Exclusion criteria

Exclusion Criteria:

Pre-existing neuropathy of the operative limb

  • Younger than 18 years old and older than 80
  • Patients with pulmonary severe respiratory disease
  • Allergy to one of the study medications
  • Chronic gabapentin/pregabalin use (regular use for longer than 3 months)
  • Chronic opioid use (taking opioids for longer than 3 months)
  • to general anesthesia, interscalene or superior trunk block
  • Herniated Cervical Disk, Cervical Myelopathy
  • >35
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
126 participants (actual)

Study arms

  • Experimental
    interscalene block (ISB)

    The interscalene block will be done using an ultrasound-guided, in-plane approach. The anesthesiologists will target below the C5 nerve root. A 22 gauge 1.5-2 inch needle is advanced in-plane from lateral to medial through the middle scalene muscle until the needle tip is positioned in the interscalene groove between the C5 and C6 nerve roots. 15 20 ml of 0.5% bupivacaine will be injected.

    Drug: Bupivacaine · Device: Ultrasound

  • Experimental
    superior trunk block (STB)

    The superior trunk block will be performed at the point immediately distal to the roots when the c5-c6 form the superior trunk and lies anterior to the middle scalene muscle and below the deep cervical fascia, before the suprascapular nerve arises and goes into the omohyoid. A 22g 1.5-2inch needle will be advanced in-plane from lateral to medial. The needle tip will be placed lateral to the superior trunk and 15 20 ml of 0.5% bupivacaine will be injected just inferior to the deep cervical fasica. Local circumferential spread will be achieved both anterior and posterior to the superior trunk.

    Drug: Bupivacaine · Device: Ultrasound

Interventions

  • Anesthetic that will help treat pain and sensation after shoulder arthroscopy

  • DeviceUltrasound

    Ultrasound will help guide the anesthesiologist in performing the different nerve blocks

06

What researchers measure

Primary outcomes

  1. Number of Participants With Incidence of Hemidiaphragmatic Paralysis (HDP)

    Our primary outcome will be the incidence of hemidiaphragmatic paralysis (HDP) with superior trunk block and interscalene blocks as measured by ultrasound before and after the surgery.

    Time frame: Day of Surgery, diagnosis confirmed from trained anesthesiologist ultrasound readers

  2. Numerical Pain Rating System (NRS) Pain Scores

    Numerical Pain Rating System Pain scores after the superior trunk block and interscalene block at rest measured after the surgery every 30 minute until discharge according to the Post Anaesthetic Discharge Scoring System. Numerical Rating Scale 0-10; with 0 being no pain and 10 pain as bad as you can imagine.

    Time frame: Average pain scores at rest recorded Day of Surgery every 30 minutes until discharge according to Post Anaesthetic Discharge Scoring System

Secondary outcomes

  1. Block Duration

    Length of nerve block reported by Phone call on POD 1 and POD 2 by patient phone call

    Time frame: Time of block wearing off recorded on Post Operative Day 1 and Post Operative Day 2 as reported via patient phone call.

07

Results

Posted Apr 29, 2020

Participant flow

Participant flow — Overall Study
MilestoneInterscalene Block (ISB)Superior Trunk Block (STB)
Started6363
Completed6363
Not completed00

Outcome measures

PrimaryNumber of Participants With Incidence of Hemidiaphragmatic Paralysis (HDP)

Our primary outcome will be the incidence of hemidiaphragmatic paralysis (HDP) with superior trunk block and interscalene blocks as measured by ultrasound before and after the surgery.

Time frame:
Day of Surgery, diagnosis confirmed from trained anesthesiologist ultrasound readers
Reported as:
Number · participants
Number of Participants With Incidence of Hemidiaphragmatic Paralysis (HDP)
participantsInterscalene Block (ISB)Superior Trunk Block (STB)
HDP453
No HDP1859
PrimaryNumerical Pain Rating System (NRS) Pain Scores

Numerical Pain Rating System Pain scores after the superior trunk block and interscalene block at rest measured after the surgery every 30 minute until discharge according to the Post Anaesthetic Discharge Scoring System. Numerical Rating Scale 0-10; with 0 being no pain and 10 pain as bad as you can imagine.

Time frame:
Average pain scores at rest recorded Day of Surgery every 30 minutes until discharge according to Post Anaesthetic Discharge Scoring System
Reported as:
Median · units on a scale
Numerical Pain Rating System (NRS) Pain Scores
units on a scaleInterscalene Block (ISB)Superior Trunk Block (STB)
Numerical Pain Rating System (NRS) Pain Scores0 (0 to 2)0 (0 to 3)
SecondaryBlock Duration

Length of nerve block reported by Phone call on POD 1 and POD 2 by patient phone call

Time frame:
Time of block wearing off recorded on Post Operative Day 1 and Post Operative Day 2 as reported via patient phone call.
Reported as:
Median · Hours
Block Duration
HoursInterscalene Block (ISB)Superior Trunk Block (STB)
Block Duration23.18 (19.95 to 25.53)23.15 (19.12 to 30.07)

Adverse events

Collected over From Post Op Day 1 to Post Op Day 7. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Interscalene Block (ISB)0/63 (0%)0/63 (0%)0/63 (0%)
Superior Trunk Block (STB)0/63 (0%)0/63 (0%)0/63 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Interscalene Block (ISB)Superior Trunk Block (STB)Total
Median50.0 (38.0 to 59.0)51.5 (37.0 to 60.0)51 (37 to 59)
Sex: Female, Male
Sex: Female, Male(Participants)Interscalene Block (ISB)Superior Trunk Block (STB)Total
Female191433
Male444993
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Interscalene Block (ISB)Superior Trunk Block (STB)Total
Hispanic or Latino448
Not Hispanic or Latino5858116
Unknown or Not Reported112
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Interscalene Block (ISB)Superior Trunk Block (STB)Total
American Indian or Alaska Native000
Asian202
Native Hawaiian or Other Pacific Islander011
Black or African American448
White5254106
More than one race000
Unknown or Not Reported549
BMI
BMI(kg/m^2)Interscalene Block (ISB)Superior Trunk Block (STB)Total
Median26.8 (24.4 to 29.6)27.2 (24.8 to 29.8)26.8 (24.8 to 29.8)
Length of Surgery
Length of Surgery(minutes)Interscalene Block (ISB)Superior Trunk Block (STB)Total
Median46.0 (35.0 to 66.0)49.0 (32.0 to 62.0)48 (33 to 63)
ASA Class
ASA Class(participants)Interscalene Block (ISB)Superior Trunk Block (STB)Total
ASA 1181028
ASA 2445296
ASA 3112
Laterality
Laterality(participants)Interscalene Block (ISB)Superior Trunk Block (STB)Total
LEFT Shoulder Arthroscopy282351
Right Shoulder Arthroscopy354075

1 further baseline measures are reported on the registry.

08

Study locations

1 site
  • Hospital for Special Surgery
    New York, New York 10021, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 11, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03272139
Responsible party
Sponsor
First posted
Sep 5, 2017
Start date
Sep 28, 2017
Primary completion
Dec 30, 2018
Completion
Jul 9, 2019
Results posted
Apr 29, 2020
Last update
May 11, 2022

Study contacts

David H Kim, MD
principal investigator · Hospital for Special Surgery, New York

Oversight

FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Bupivacaine

Start the discussion